Adults don’t trust health care to use AI responsibly and without harm

Study notes hospitals should increase or improve their communications with patients about using artificial intelligence tools

2025-02-14

(Press-News.org) A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care systems to make sure an AI tool would not harm them.

The research letter was published in JAMA Network Open.

Adults who had higher levels of overall trust in their health care systems were more likely to believe their providers would protect them from AI-related harm.

The letter, authored by Jodyn Platt, Ph.D., of the Department of Learning Health Sciences at University of Michigan Medical School and Paige Nong, Ph.D., of the University of Minnesota School of Public Health comes from survey of a nationally representative sample of adults from the National Opinion Research Center’s AmeriSpeak Panel from June to July 2023.

Additional insights include that female respondents were less likely than male respondents to trust their health care systems to use AI responsibility.

Health literacy or AI knowledge were not associated with trust in AI, suggesting that building trust in the use of AI will require meaningful engagement.

The authors note that future research should look at trust over time and with increased familiarity with AI.

Furthermore, health systems that adopt AI should increase or improve their communication about the tools used in patient care.

Paper cited: "Patients’ Trust in Health Systems to Use Artificial Intelligence", JAMA Network Open. DOI:10.1001/jamanetworkopen.2024.60628

END

ELSE PRESS RELEASES FROM THIS DATE:

INSEAD webinar on the dual race to AI & global leadership

2025-02-14

Digital@INSEAD is hosting a free TECH TALK X webinar “The Dual Race to AI & Global Leadership” on Wednesday, 19 February 2025 7.00 am ET / 1.00 pm CET (Duration: 60 min). The TECH TALK will be featuring a discussion between Tim Gordon (MBA’00D), Partner, Best Practice AI and Theos Evgeniou, INSEAD Professor of Technology & Business and Director of Executive Programs in AI. Tim, an INSEAD alumnus with over 20 years of international experience in digital transformation, global strategy and innovation, will join Theos to explore the two critical AI races reshaping our world: ...

Ketamine: From club drug to antidepressant?

2025-02-14

Ketamine has received a Hollywood makeover. It used to be known as a rave drug (street name special K) and cat anesthetic. However, in recent years, some doctors have prescribed ketamine to treat conditions from post-traumatic stress disorder to depression. “The practice is not without controversy,” notes Cold Spring Harbor Laboratory (CSHL) Professor Hiro Furukawa. ‘Should we give a hallucinogen to patients in compromised mental states?’ wonder ketamine’s skeptics. The controversy came to ...

Multilevel stressors and systemic and tumor immunity in Black and White women with breast cancer

2025-02-14

About The Study: The findings of this cross-sectional study of Black and white women with breast cancer suggest that perceived stress, perceived inadequate social support, perceived racial and ethnic discrimination, and neighborhood deprivation were associated with deleterious alterations to the systemic and tumor immune environment, particularly for Black women. Understanding biology as a possible mediator of cancer health disparities may inform prevention and public health interventions. Corresponding Author: To contact ...

Childhood lifestyle behaviors and mental health symptoms in adolescence

2025-02-14

About The Study: This cohort study of Finnish children and adolescents found that higher physical activity and lower screen time from childhood were associated with perceived stress and depressive symptoms in adolescence. These findings emphasize reducing screen time and increasing physical activity to promote mental health in youth. Corresponding Author: To contact the corresponding author, Eero A. Haapala, PhD, email eero.a.haapala@jyu.fi. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.60012) Editor’s Note: Please see the ...

Most comprehensive study on U.S. health care spending by county reveals wide variation

2025-02-14

At $144 billion, type 2 diabetes was the most expensive single health condition. Emergency department care had the fastest growth. SEATTLE, Wash., Feb. 14, 2025 – Researchers present the most comprehensive study on U.S. health care spending and variations across 3,110 counties by four payers, 148 health conditions, 38 age/sex groups, and seven types of care. That’s according to the newest and most extensive studies published in JAMA and JAMA Health Forum today. As part of this study, researchers ...

Tracking U.S. health care spending by health condition and county

2025-02-14

About The Study: Broad variation in health care spending was observed across U.S. counties. Understanding this variation by health condition, sex, age, type of care, and payer is valuable for identifying outliers, highlighting inequalities, and assessing health care gaps. Corresponding Author: To contact the corresponding author, Joseph L. Dieleman, PhD, email dieleman@uw.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2024.26790) Editor’s ...

Drivers of variation in health care spending across U.S. counties

2025-02-14

About The Study: In this cross-sectional study, variation in health care spending among U.S. counties was largely related to variation in service utilization. Understanding the drivers of spending variation in the U.S. may help policymakers assess the allocation of health care resources. Corresponding Author: To contact the corresponding author, Joseph L. Dieleman, PhD, email dieleman@uw.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2024.5220) Editor’s ...

INSEAD webinar on scaling affordable healthcare: balancing purpose, innovation & growth

2025-02-14

Digital@INSEAD is hosting a free INTHECASE webinar, “Scaling Affordable Healthcare: Balancing Purpose, Innovation & Growth” on Thursday, 20 February 2025 at 9.00 am ET / 3.00 pm CET (60 min). Register and join the webinar for an engaging discussion on Access Afya’s journey to scale its affordable healthcare model while staying true to its mission of serving underserved communities. Explore how the company: Balances mission and growth Navigates the complexities of scaling up Leverages technology and data to improve care delivery With a proven business model in Kenya, ...

A new switch for the cell therapies of the future

2025-02-14

The body regulates its metabolism precisely and continuously, with specialised cells in the pancreas constantly monitoring the amount of sugar in the blood, for example. When this blood sugar level increases after a meal, the body sets a signal cascade in motion in order to bring it back down. In people suffering from diabetes, this regulatory mechanism no longer works exactly as it should. Those affected therefore have too much sugar in their blood and need to measure their blood sugar level and inject themselves with insulin in order to regulate it. This is ...

Utilizing a nanomedicine to achieve tumor catalysis-enhanced differentiation therapy

2025-02-14

Tumor metastasis, recurrence, and therapeutic resistance are the main reasons for the failure of clinical cancer treatment. Studies have found that the presence of cancer stem-like cells (CSCs) with stemness characteristics in malignant tumors is a key factor leading to the above undesirable results. However, there are significant limitations to current strategies with traditional molecular drugs for combating CSCs, such as the unsatisfactory in vivo stemness-suppressing efficiency, and the lack of powerful tumor-specific lethal action, resulting in remaining massive bulk tumor cells that can convert to CSCs via epithelial-to-mesenchymal ...

LAST 30 PRESS RELEASES:

Dual-target CAR T cell therapy slows growth of aggressive brain cancer

Adding immune checkpoint inhibitor to standard chemotherapy regimen improves outcomes in stage 3 colon cancer, study finds

Diet influences survival after stage iii colon cancer, Dana-Farber study finds

Switch to experimental drug after liquid biopsy detection of breast cancer recurrence improves outcomes

Alliance presents results from phase III ATOMIC trial combining atezolizumab with chemotherapy for patients with stage III dMMR colon cancer at ASCO 2025